BioCentury
ARTICLE | Clinical News

Oral phentolamine: Began Phase II trials in Germany in 160 patients; an IND is expected to be filed in the U.S. this year

January 30, 1995 8:00 AM UTC

Zonagen Inc. (ZONA), The Woodlands, Texas Product: Oral phentolamine Indication: Male impotency Status: Began Phase II trials in Germany in 160 patients; an IND is expected to be filed in the U.S. thi...